$ABT

AI 分析

生成於 May 18, 2026

AI Score
73/ 100
Buy$ABT

Abbott Laboratories

$ABTNYSEHealthcareLarge-Cap

Abbott discovers, develops, manufactures, and sells health care products worldwide in diagnostics, medical devices, nutrition, and pharmaceuticals.

Market Cap
$210B
Revenue (TTM)
$42.5B
+5.8%
Net Income (TTM)
$7.8B
+8.2%
EPS (TTM)
$4.52
P/E Ratio
26.8
Dividend Yield
1.8%
52-Week Range
$102-$128
Beta
0.72
Dimension Scores
Fundamental
76
Technical
70
Sentiment
72
Risk / Reward
74
Momentum
68
FundTechSentRiskMome
Financial Health
Profitability
78moderate
Growth
68moderate
Liquidity
80strong
Solvency
78moderate
Efficiency
76moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $ABT

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。